Search

everythinglearnresearchcommunity

for

Search:↓

Low iron levels are linked to hair loss in women.

Many people with hair loss had low iron and ferritin levels.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Hairless mice lack fur due to a genetic mutation affecting skin response, not hormone issues.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Higher doses of spironolactone may improve acne in PCOS patients, but side effects are a concern.

Combining letrozole with metformin is the most effective treatment for inducing pregnancy in women with PCOS.

Anorexia and bulimia lead to serious health problems and increased risk of death, requiring aggressive treatment.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Lower SHBG levels may increase the risk of PCOS.

Congenital Adrenal Hyperplasia is a rare inherited disease causing hormone imbalances, affecting growth, fertility, and heart health, diagnosed through blood tests and treated with medication and lifestyle changes.

Most women lack knowledge about androgens and their excess symptoms.

Sarcoptes scabiei infection causes significant health and behavior changes in wombats.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The article suggests that five common skin-related lab tests may be unnecessary and could cause extra cost and anxiety without improving patient care.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.